Elutia (ELUT) News
NASDAQ: ELUTHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
ELUT news summary
We found 4 recent headlines mentioning Elutia (ELUT): 1 in the past week and 3 in the past 30 days, most often from GlobeNewswire, Nasdaq. ELUT is making an outsized move today, up 11.12% at $0.9001, which often coincides with company-specific news. Check the latest headlines below for the likely catalyst. The most recent story, "Elutia Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4)", was published by GlobeNewswire on Nov 17, 2026.
Headlines link to the original publishers. MetaCap does not republish third-party articles.
Summary generated from market data by MetaCap's automated system. Methodology
Latest Elutia headlines
- Elutia Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4)Elutia Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4)GlobeNewswire
- Elutia Inc. Reports Third Quarter 2026 Results and Plans NXT-41x FDA SubmissionElutia Inc. reported its financial results for the third quarter ended September 30, 2026, and provided updates on its product pipeline. The company announced that it intends to submit NXT-41x, its…Nasdaq
- Elutia Reports Third Quarter 2026 Results: As Plastic Surgeons Cite Infection Risk in Every Breast Research Session During National Meeting, NXT-41x Heads to FDA This Quarter, Fully Funded Through LaunchElutia Reports Q3 2026 Results: As Plastic Surgeons Cite Infection Risk at National Meeting, NXT-41x Heads to FDA This Quarter, Fully Funded Through LaunchGlobeNewswire
- Elutia to Report Third Quarter 2026 Financial Results on Thursday, November 5, 2026Elutia announced that it will release its third quarter 2026 financial results after market close on Thursday, November 5, 2026.GlobeNewswire